Persistence of circulating tumor cells in high risk early breast cancer patients five years after adjuvant chemotherapy and late recurrence: Results from the adjuvant SUCCESS A trial.

Authors

null

Wolfgang Janni

University of Ulm, Ulm, Germany

Wolfgang Janni , Brigitte Kathrin Rack , Peter A. Fasching , Lothar Haeberle , Hans Tesch , Ralf Lorenz , Fabienne Schochter , Marie Tzschaschel , Amelie De Gregorio , Tanja N. Fehm , Volkmar Müller , Andreas Schneeweiss , Werner Lichtenegger , Matthias W. Beckmann , Christoph Scholz , Klaus Pantel , Thomas W. P. Friedl

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT02181101

Citation

J Clin Oncol 36, 2018 (suppl; abstr 515)

DOI

10.1200/JCO.2018.36.15_suppl.515

Abstract #

515

Poster Bd #

7

Abstract Disclosures

Similar Posters